Cloverleaf Bio
Cloverleaf Bio is seeking an experienced In Vivo Scientist to join its founding team in Boston, MA, to develop a novel class of engineered RNA therapeutics. The role involves designing and executing in-house animal experiments, coordinating studies at CROs, and performing in vitro experiments to characterize candidate RNAs. This position requires providing in vivo pharmacology and physiology expertise to accelerate the development of tRNA therapeutics.
Cloverleaf Bio is a biotechnology company developing a new class of RNA therapeutics to revolutionize cancer therapy. The company recently raised a $33M seed round to advance its pipeline. It is currently hiring and actively growing its team.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cloverleaf Bio.
Cloverleaf Bio didn’t post a salary, so this is our estimate from similar listings.
Senior Scientist/Principal Scientist, ADC Biology & Biomarker Discovery
Hexagon Bio
Senior/Principal Scientist, Discovery Oncology (in vivo Biology)
Eli Lilly and Company
Advisor – RNA Preclinical Pharmacology
Eli Lilly and Company
Senior Research Investigator, Biologics Pharmacology, London
Isomorphic Labs
Scientist, In Vivo Pharmacology
AstraZeneca
Senior Scientist – In Vivo Pharmacology, Oncology R&D
AstraZeneca